FDA approves ‘game-changing’ pancreatic cancer drug
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 26 August 2026
What it is about
Rasonque RasonqueRachna ShroffBen SasseNew York TimesAmerican Cancer SocietyUniversity Of North Carolina At Chapel HillUniversity Of Arizona Cancer CenterDrug Administration OnNew York, United StatesNebraska, United StatesAmerican
Who published it, and when
How it spread - 1 original report
Wed, 26 August 2026
1 report- nbcnews.com18:47first to report
In a late-stage trial, people who got Revolution Medicines’ Rasonque, or daraxonrasib, lived about twice as long as people who got standard care.